These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 14508086

  • 1. Farnesyl transferase inhibitors: mechanism of action, translational studies and clinical evaluation.
    Bishop WR, Kirschmeier P, Baum C.
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S96-104. PubMed ID: 14508086
    [No Abstract] [Full Text] [Related]

  • 2. Farnesyltransferase inhibitors: targeting the molecular basis of cancer.
    Oliff A.
    Biochim Biophys Acta; 1999 May 31; 1423(3):C19-30. PubMed ID: 10382537
    [No Abstract] [Full Text] [Related]

  • 3. Farnesyltransferase inhibitors.
    Adjei AA.
    Cancer Chemother Biol Response Modif; 2001 May 31; 19():149-64. PubMed ID: 11686012
    [No Abstract] [Full Text] [Related]

  • 4. Farnesyltransferase inhibitors.
    Adjei AA.
    Cancer Chemother Biol Response Modif; 2002 May 31; 20():151-67. PubMed ID: 12703204
    [No Abstract] [Full Text] [Related]

  • 5. Clinical activity of farnesyl transferase inhibitors in hematologic malignancies: possible mechanisms of action.
    Jabbour E, Kantarjian H, Cortes J.
    Leuk Lymphoma; 2004 Nov 31; 45(11):2187-95. PubMed ID: 15512806
    [Abstract] [Full Text] [Related]

  • 6. Sch-66336 (sarasar) and other benzocycloheptapyridyl farnesyl protein transferase inhibitors: discovery, biology and clinical observations.
    Taveras AG, Kirschmeier P, Baum CM.
    Curr Top Med Chem; 2003 Nov 31; 3(10):1103-14. PubMed ID: 12769711
    [Abstract] [Full Text] [Related]

  • 7. Ras biochemistry and farnesyl transferase inhibitors: a literature survey.
    Crul M, de Klerk GJ, Beijnen JH, Schellens JH.
    Anticancer Drugs; 2001 Mar 31; 12(3):163-84. PubMed ID: 11290863
    [Abstract] [Full Text] [Related]

  • 8. Pre-clinical development of farnesyltransferase inhibitors.
    Lobell RB, Kohl NE.
    Cancer Metastasis Rev; 1998 Jun 31; 17(2):203-10. PubMed ID: 9770117
    [Abstract] [Full Text] [Related]

  • 9. Perspectives on farnesyl transferase inhibitors in cancer therapy.
    Mazieres J, Pradines A, Favre G.
    Cancer Lett; 2004 Apr 08; 206(2):159-67. PubMed ID: 15013521
    [Abstract] [Full Text] [Related]

  • 10. Farnesyl transferase inhibitors in the treatment of breast cancer.
    Kelland LR.
    Expert Opin Investig Drugs; 2003 Mar 08; 12(3):413-21. PubMed ID: 12605564
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. RAS inhibitors: potential for cancer therapeutics.
    Kloog Y, Cox AD.
    Mol Med Today; 2000 Oct 08; 6(10):398-402. PubMed ID: 11006529
    [Abstract] [Full Text] [Related]

  • 14. Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects.
    Prendergast GC.
    Curr Opin Cell Biol; 2000 Apr 08; 12(2):166-73. PubMed ID: 10712917
    [Abstract] [Full Text] [Related]

  • 15. Farnesyltransferase inhibitors as anticancer agents: current status.
    Zhu K, Hamilton AD, Sebti SM.
    Curr Opin Investig Drugs; 2003 Dec 08; 4(12):1428-35. PubMed ID: 14763128
    [Abstract] [Full Text] [Related]

  • 16. [Development of farsenyl transferase inhibitors as anticancer agents].
    Cestac P, Doisneau-Sixou S, Favre G.
    Ann Pharm Fr; 2005 Jan 08; 63(1):76-84. PubMed ID: 15803104
    [Abstract] [Full Text] [Related]

  • 17. Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777.
    Wright J, Blatner GL, Cheson BD.
    Oncology (Williston Park); 1999 Nov 08; 13(11):1527, 1530, 1533. PubMed ID: 10581601
    [No Abstract] [Full Text] [Related]

  • 18. Farnesyl transferase inhibitors--a novel therapy for breast cancer.
    Johnston SR, Kelland LR.
    Endocr Relat Cancer; 2001 Sep 08; 8(3):227-35. PubMed ID: 11566614
    [Abstract] [Full Text] [Related]

  • 19. Farnesyl protein transferase inhibition: a novel approach to anti-tumor therapy. the discovery and development of SCH 66336.
    Ganguly AK, Doll RJ, Girijavallabhan VM.
    Curr Med Chem; 2001 Oct 08; 8(12):1419-36. PubMed ID: 11562275
    [Abstract] [Full Text] [Related]

  • 20. Farnesyltransferase inhibitors.
    Hahn SM, Bernhard E, McKenna WG.
    Semin Oncol; 2001 Oct 08; 28(5 Suppl 16):86-93. PubMed ID: 11706400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.